DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Terasawa T. et al.
Bezafibrate, a peroxisome proliferator-activated receptor alpha agonist, decreases circulating CD14(+)CD16(+) monocytes in patients with type 2 diabetes.
Translat Res 2015;
165: 336-345.
We do not assume any responsibility for the contents of the web pages of other providers.